All ResourcesUpdates Treatment Options for Cervical cancer Cervical cancer, though preventable and curable, remains a significant global public health…Invimeds HealthJanuary 16, 2024
NewsUpdates FDA Grants Approval To Avzivi, Marking The Fifth Biosimilar To Avastin The FDA has approved Avzivi (bevacizumab-tnjn), the fifth biosimilar of bevacizumab developed…Invimeds HealthJanuary 10, 2024
All ResourcesEvents Cervical Health Awareness Month: Theme, History, Statistics Introduction Cervical Health Awareness Month is marked in January, a time dedicated…Invimeds HealthJanuary 5, 2024
All ResourcesEvents International Mind-Body Wellness Day On January 3rd, we celebrate International Mind-Body Wellness Day, a time dedicated…Invimeds HealthJanuary 3, 2024
News FDA Approves Enzalutamide for Non-Metastatic Castration-Sensitive Prostate Cancer: A Game-Changer in Treatment We're thrilled to share groundbreaking news in the realm of oncology: On…Invimeds HealthDecember 19, 2023
All ResourcesEvents Universal Health Coverage (UHC) Day 2023 Universal Health Coverage (UHC) Day, is observed annually on December 12th. This…Invimeds HealthDecember 12, 2023
All ResourcesNews Fda approves wezlana as an interchangeable biosimilar to stelara for Multiple Inflammatory Diseases The US Food and Drug Administration (FDA) has approved Wezlana (ustekinumab-auub) as…Invimeds HealthNovember 2, 2023
All ResourcesEvents Navigating the Future of the Healthcare Industry: Insights into CPhI Europe The healthcare sector has been brought to the forefront of global innovation…Invimeds HealthSeptember 8, 2023
All ResourcesLatest Approval FDA approves Sandoz Tyruko for the treatment of multiple sclerosis Tyruko (natalizumab-site), a natalizumab biosimilar, has been authorized by the FDA as…Invimeds HealthSeptember 8, 2023
All ResourcesNews Horizon Therapeutics takes the rare disease reputation crown Another wreath has been added to Horizon Therapeutics' pre-takeover victory lap. Months…Invimeds HealthSeptember 1, 2023